Therapeutic Antibodies – News and Features
News
Alder Biopharmaceuticals Forms Collaboration with Schering-Plough
The collaboration will use Alder's antibody selection system to identify and produce antibodies.
News
Avid Bioservices Announces Bioproduction Contract with Major Leading Cancer Center
Avid Bioservices will manage process development and cGMP manufacturing for drug candidate.
News
Seattle Genetics to Present on ADC Technology
The presentations demonstrate the key advances to empower the next generation of targeted cancer therapies.
News
Morphotek Announces Collaboration with the JWCI
Morphotek will apply its proprietary Human MORPHODOMA® antibody technology to develop antibodies.
News
MorphoSys and Wacker Demonstrate High Yield Expression of Antibody Fragments
MorphoSys obtains the right to use Wacker's secretion system for antibody-fragment production.
News
ACE Biosciences and Crucell Collaborate to Discover Antibody Therapies
Crucell gains rights to assay a number of proprietary protein targets that ACE BioSciences has isolated.
News
BioWa and OncoTherapy Collaborate to Develop Anticancer Monoclonal Antibodies
OncoTherapy and BioWa will apply their technologies for the enhancement of antibody-dependent cellular cytotoxicity.
News
Roche and Epitomics Enter Into Monoclonal Antibody Technology Research Agreement
Agreement will help in the discovery and development of monoclonal antibodies to treat cancer and other diseases.
News
Immune Therapy Could Treat Leukemias, Autoimmune Diseases and Transplant Rejection
Monoclonal antibody has shown promise for treating leukemias, autoimmune diseases and transplant rejection.
News
MorphoSys Starts Multiple Antibody Programs with Schering
MorphoSys announces the start of a further three therapeutic antibody programs within the scope of its collaboration with Schering.
Advertisement
